AHA/ACS/AUA androgen-deprivation therapy in prostate cancer and cardiovascular risk

Source:
American Heart Association
Publisher:
American Heart Association
Publication date:
01 February 2010

Abstract

Androgen-deprivation therapy (ADT) is a widely used treatment for prostate cancer. Recently, several studies have reported an association between ADT and an increased risk of cardiovascular events, including myocardial infarction and cardiovascular mortality.